Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04037020 · ClinicalTrials.gov registry record
The Chocolate Study 2.0
A clinical trial, sponsored by USDA Grand Forks Human Nutrition Research Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT04037020: Completed study, sponsored by USDA Grand Forks Human Nutrition Research Center.
NCT04037020 is a clinical trial that has completed, run by USDA Grand Forks Human Nutrition Research Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04037020 has completed, sponsored by USDA Grand Forks Human Nutrition Research Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to test how the brain responds when enjoyable foods such as chocolate are consumed. The investigators know that eating certain types of foods can make an individual want to keep eating even when he or she is full. The chemical in the brain that causes this is called dopamine. The investigators can measure this response by looking at changes to how an individual's eye responds to light.
Primary Outcome
Electroretinograph b-wave amplitude will increase in response to increases in the amount of sugar in the chocolate.
Interventions
- OTHER Chocolate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-07-25 |
| Est. Completion | 2019-09-05 |
What the finished NCT04037020 record still lists
NCT04037020 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Chocolate is the first listed.
NCT04037020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04037020 about?
NCT04037020 is a clinical study titled "The Chocolate Study 2.0". The purpose of this study is to test how the brain responds when enjoyable foods such as chocolate are consumed. The investigators know that eating certain types of foods can make an individual want to keep eating even when he or she is full. The chemical in the brain that causes this is called dopa...
What is the current status of trial NCT04037020?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-07-25. Estimated completion is 2019-09-05.
What interventions are being tested in trial NCT04037020?
The interventions under investigation include: Chocolate (OTHER).
Who is sponsoring clinical trial NCT04037020?
This trial is sponsored by USDA Grand Forks Human Nutrition Research Center, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI